Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
02 07 2021
Historique:
received: 17 02 2021
accepted: 30 03 2021
pubmed: 7 4 2021
medline: 20 7 2021
entrez: 6 4 2021
Statut: ppublish

Résumé

Herein we measured CD4+ T-cell responses against common cold coronaviruses (CCC) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in high-risk health care workers (HCW) and community controls. We observed higher levels of CCC-reactive T cells in SARS-CoV-2-seronegative HCW compared to community donors, consistent with potential higher occupational exposure of HCW to CCC. We further show that SARS-CoV-2 T-cell reactivity of seronegative HCW was higher than community controls and correlation between CCC and SARS-CoV-2 responses is consistent with cross-reactivity and not associated with recent in vivo activation. Surprisingly, CCC T-cell reactivity was decreased in SARS-CoV-2-infected HCW, suggesting that exposure to SARS-CoV-2 might interfere with CCC responses, either directly or indirectly. This result was unexpected, but consistently detected in independent cohorts derived from Miami and San Diego. CD4+ T-cell responses against common cold coronaviruses (CCC) are elevated in SARS-CoV-2 seronegative high-risk health care workers (HCW) compared to COVID-19 convalescent HCW, suggesting that exposure to SARS-CoV-2 might interfere with CCC responses and/or cross-reactivity associated with a protective effect.

Identifiants

pubmed: 33822097
pii: 6209393
doi: 10.1093/infdis/jiab176
pmc: PMC8083569
doi:

Substances chimiques

Antibodies, Viral 0
Biomarkers 0
Epitopes, T-Lymphocyte 0
Peptides 0
Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

70-80

Subventions

Organisme : NIAID NIH HHS
ID : R25 AI147376
Pays : United States
Organisme : NIAID NIH HHS
ID : HHSN272201400008C
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI141995
Pays : United States
Organisme : University of Miami Institutional Support
Organisme : Open Philanthropy Project
ID : 2020-215611
Organisme : NIAID NIH HHS
ID : R01 AI135193
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG068110-01A1
Pays : United States
Organisme : NIAID NIH HHS
ID : 75N93019C00051
Pays : United States
Organisme : Miami Clinical and Translational Science Institute Emerging Disease Proposal
Organisme : NCI NIH HHS
ID : U01 CA260541
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : AI142742
Organisme : NIH HHS
ID : 75N9301900065
Pays : United States
Organisme : JPB Foundation
Organisme : NIA NIH HHS
ID : R01 AG068110
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI142742
Pays : United States

Commentaires et corrections

Type : UpdateOf

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Références

Nature. 2020 Aug;584(7821):457-462
pubmed: 32668444
BMC Infect Dis. 2019 Jun 3;19(1):491
pubmed: 31159777
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Health Secur. 2021 Mar-Apr;19(2):195-208
pubmed: 33186086
J Infect Dis. 2021 Jan 4;223(1):56-61
pubmed: 33128369
Am J Infect Control. 2009 Jun;37(5):417-419
pubmed: 19216002
Science. 2020 Oct 2;370(6512):89-94
pubmed: 32753554
Front Immunol. 2020 Oct 15;11:567710
pubmed: 33178193
J Immunol. 2005 Jul 1;175(1):591-8
pubmed: 15972696
Cell Rep Med. 2021 Feb 16;2(2):100204
pubmed: 33521695
Science. 2020 Aug 7;369(6504):718-724
pubmed: 32661059
Int J Infect Dis. 2021 Jan;102:63-69
pubmed: 33075539
BMC Pulm Med. 2020 Jul 29;20(1):203
pubmed: 32727446
Front Immunol. 2020 Oct 16;11:586984
pubmed: 33178220
J Clin Virol. 2018 Apr;101:52-56
pubmed: 29427907
Lancet Infect Dis. 2020 Dec;20(12):1401-1408
pubmed: 32758438
J Clin Invest. 2021 Jan 4;131(1):
pubmed: 32997649
BMC Infect Dis. 2018 Apr 17;18(1):184
pubmed: 29665775
Cell. 2020 Oct 1;183(1):158-168.e14
pubmed: 32979941
Clin Microbiol Infect. 2020 Dec;26(12):1670-1675
pubmed: 32911080
Nat Commun. 2020 Oct 8;11(1):5064
pubmed: 33033249
PLoS Pathog. 2019 Jan 24;15(1):e1007474
pubmed: 30677097
Nat Immunol. 2021 Jan;22(1):74-85
pubmed: 32999467
Cell. 2020 Nov 12;183(4):996-1012.e19
pubmed: 33010815
JAMA. 2020 Sep 1;324(9):893-895
pubmed: 32780804
Curr Protoc Microbiol. 2020 Jun;57(1):e100
pubmed: 32302069
J Virol. 2020 May 4;94(10):
pubmed: 32132233
J Virol. 2014 Oct;88(19):11034-44
pubmed: 25056892
J Clin Invest. 2018 Aug 31;128(9):3853-3865
pubmed: 29920186
J Immunol. 2013 Sep 1;191(5):2486-94
pubmed: 23885108
Immunity. 2020 Dec 15;53(6):1258-1271.e5
pubmed: 33296686
Nature. 2020 Nov;587(7833):270-274
pubmed: 32726801
J Immunol Res. 2015;2015:763461
pubmed: 26568965
J Virol. 2003 Jan;77(1):68-76
pubmed: 12477811
Cell Host Microbe. 2020 Apr 8;27(4):671-680.e2
pubmed: 32183941
PLoS One. 2017 Jan 12;12(1):e0169086
pubmed: 28081174
Nat Rev Immunol. 2020 Nov;20(11):709-713
pubmed: 33024281
J Clin Invest. 2021 Jan 4;131(1):
pubmed: 33216734
Sci Immunol. 2020 Jul 15;5(49):
pubmed: 32669287
J Immunol. 2017 Nov 1;199(9):3360-3368
pubmed: 28978689
J Clin Invest. 2020 Dec 1;130(12):6631-6638
pubmed: 32966269
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
Immunity. 2021 Feb 9;54(2):340-354.e6
pubmed: 33567252
J Infect Dis. 2020 Jun 16;222(1):17-25
pubmed: 32296837

Auteurs

Ricardo da Silva Antunes (R)

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.

Suresh Pallikkuth (S)

Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA.

Erin Williams (E)

Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, USA.

Esther Dawen Yu (E)

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.

Jose Mateus (J)

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.

Lorenzo Quiambao (L)

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.

Eric Wang (E)

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.

Stephen A Rawlings (SA)

Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego , La Jolla, California, USA.

Daniel Stadlbauer (D)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Kaijun Jiang (K)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Fatima Amanat (F)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

David Arnold (D)

Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, USA.

David Andrews (D)

Department of Pathology, University of Miami Miller School of Medicine, Miami, Florida, USA.

Irma Fuego (I)

Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, USA.

Jennifer M Dan (JM)

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.
Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego , La Jolla, California, USA.

Alba Grifoni (A)

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.

Daniela Weiskopf (D)

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.

Florian Krammer (F)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Shane Crotty (S)

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.
Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego , La Jolla, California, USA.

Michael E Hoffer (ME)

Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, USA.
Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.

Savita G Pahwa (SG)

Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA.

Alessandro Sette (A)

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.
Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego , La Jolla, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH